Spellman David A has filed 6 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 63567 shares of Akebia Therapeutics, Inc. ($AKBA) on May 16, 2023.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | Akebia Therapeutics, Inc. | $AKBA | Spellman David A | SVP, CFO and Treasurer | S | Common Stock | 63567 | $1.07 | 446,483.0000 | 0 | 12.46% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Spellman David A | SVP, CFO and Treasurer | S | Common Stock | 6400 | $0.88 | 510,860.0000 | 0 | 1.24% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Spellman David A | SVP, CFO and Treasurer | S | Common Stock | 810 | $0.88 | 510,050.0000 | 0 | 0.16% | 0.00% |
| Feb. 27, 2023 | Akebia Therapeutics, Inc. | $AKBA | Spellman David A | SVP, CFO and Treasurer | S | Common Stock | 7539 | $0.81 | 517,260.0000 | 0 | 1.44% | 0.00% |
| Jan. 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Spellman David A | SVP, CFO and Treasurer | A | Common Stock | 196200 | $0.00 | 524,799.0000 | 0 | 59.71% | 0.00% |
| Jan. 31, 2023 | Akebia Therapeutics, Inc. | $AKBA | Spellman David A | SVP, CFO and Treasurer | A | Stock Option (Right to buy) | 294300 | $0.00 | 294,300.0000 | 0 | 9999.99% | 0.00% |